What is the relationship between Somerset Therapeutics and Wintac Limited?

Somerset Therapeutics Private Limited was the original name of the company incorporated in 1990 in Bengaluru. In 2001, the company's name was changed to Wintac Limited. Wintac Limited is a Bengaluru-based pharmaceutical manufacturer specializing in generic injectables and ophthalmic formulations.

What does the company manufacture?

The company (now known as Wintac Limited) is engaged in manufacturing generic pharmaceutical products, with a focus on sterile injectables and ophthalmic drug formulations. These are regulated, high-value pharmaceutical segments that require stringent quality compliance.

Where is the company located?

The company is headquartered in Bengaluru, Karnataka, which is a major hub for pharmaceutical and biotech companies in India. Its manufacturing operations are also based in Karnataka.

Is Somerset Therapeutics / Wintac Limited planning an IPO?

No public IPO plans have been announced for Wintac Limited (formerly Somerset Therapeutics Private Limited) as of early 2025. The company remains a private entity.

How do I buy Somerset Therapeutics unlisted shares here?

Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.

Who am I actually transacting with?

You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.

How do I pay, and is there a payment gateway?

Payment is by direct bank transfer to Prospire Network Private Limited's published account (CIN U82300UP2025PTC233622), shown to you in-app at the payment step. There is no card gateway and no escrow. Never pay to a personal account or to any account shared over phone, WhatsApp or email — even if the person claims to be from our team.

How long does settlement take?

After you accept an allocation, you have a short window to pay (typically 2 days). Once payment is verified, shares are usually credited to your demat within 2–3 business days, subject to depository timelines and any company-level restrictions. Timeframes are typical, not guaranteed.

There are no separate platform fee lines and no GST on the transfer — the desk's margin is built into the buy/sell price you're quoted. The only statutory add-on on a purchase is stamp duty on the consideration, shown transparently in your cost breakdown.

Is there a minimum ticket size for Somerset Therapeutics?

Minimums vary by company and depend on the lot the desk can source. Raise an enquiry and the desk will confirm the available quantity and the minimum for that name.

What KYC do I need, and do I need a demat account?

You'll share your demat details when you enquire so we can settle directly. Full KYC — PAN and a client-master / demat statement — is required before the transfer step, when shares actually change hands. Yes, you need an active demat account to hold unlisted shares.

Are there lock-ins on unlisted or pre-IPO shares?

Some shares carry statutory or company-imposed lock-ins — for example, a post-listing lock-in on pre-IPO stock — and transfers can be subject to the company's articles or approvals. Where a lock-in applies, we'll flag it before you commit.

How do I sell Somerset Therapeutics shares I already hold?

Raise a sell enquiry with the company, quantity and your target price. The desk confirms a buying price, you transfer your shares into the desk's demat, and once the credit is verified we pay you out by bank transfer to your registered account. The desk never pays out before your shares are received.

Unlisted shares are illiquid, may be hard or impossible to sell, and are not covered by exchange settlement guarantees or investor-protection funds. Pricing is indicative, not live. Read the full Risk Disclosure before you enquire, and invest only what you can afford to lock away.

Somerset Therapeutics Unlisted Share Price | Buy Somerset Therapeutics Pre-IPO Shares — wisefolio

Investment Thesis

Somerset Therapeutics Private Limited (CIN: U85110KA1990PTC011166) is a Nelamangala-based USFDA-approved pharmaceutical manufacturer specialising in sterile injectables and ophthalmic generics for the US regulated market. Incorporated in 1990, the company holds multiple USFDA ANDAs (Ondansetron Injection, Latanoprost Ophthalmic) and operates a 507-employee plant in Bangalore Rural. FY2025 revenue of ₹298 Cr with 35% revenue CAGR and 154% EBITDA CAGR signals exceptional growth in a high-barrier, high-margin pharma segment. An unlisted mid-sized pharma gem with significant scale in a technically demanding niche.

Pros

Revenue ₹298 Cr FY2025 with 35% revenue CAGR and 154% EBITDA CAGR — exceptional growth trajectory
USFDA-approved manufacturing facility at Nelamangala, Bangalore Rural — access to US regulated market
Multiple approved ANDAs: Ondansetron Injection (20ml, 2ml) and Latanoprost Ophthalmic Solution (US FDA approvals since 2010)
High-complexity injectable and ophthalmic formulations — differentiated from commodity oral generics
507 employees — meaningful operational scale for a private pharma manufacturer
Authorized ₹50 Cr, Paid-up ₹31.60 Cr — well-capitalized for capacity expansion

Cons

Private limited — no secondary market liquidity despite ₹298 Cr revenue scale
USFDA compliance is ongoing — any 483 observations or import alerts can disrupt export revenue
Revenue predominantly from US market — single-geography concentration risk
Heavily regulated sector: FDA, Schedule M, GMP compliance requires continuous investment
Director surnames suggest regional Tamil promoter group — succession/governance questions at scale

Business Segments

Sterile injectable formulations — generic injectables for US regulated market (USFDA-approved ANDAs)

Ophthalmic solutions — Latanoprost and other ophthalmic generics for US market

Capsule formulations — generic oral capsules

Contract manufacturing/processing — compounding, filling, packaging for export clients

Plant at 54/1-54/2, Boodihal Village, Nelamangala, Bangalore Rural, Karnataka 562123

Revenue Model

The company (operating as Wintac Limited) generates revenue from manufacturing and selling generic pharmaceutical products — primarily sterile injectables and ophthalmic formulations — to domestic distributors, hospitals, and export markets. Revenue is driven by production volumes, product mix, and regulatory approvals in target markets.

Detailed Analysis

Growth outlookExpansion plans, industry tailwinds & headwinds9

Growth Plans

Growing global demand for generic sterile injectables, particularly from regulated markets

India's cost-competitive pharmaceutical manufacturing base driving export opportunities

Increasing domestic hospital and healthcare spending boosting injectable formulation demand

Industry Tailwinds

Growing global demand for generic sterile injectables, particularly from regulated markets

Recent Developments

FY2025: Revenue ₹298 Cr, 1-year revenue CAGR 35%, EBITDA CAGR 154% — strong operational leverage

FY2024: Revenue ₹100-500 Cr range with EBITDA +146.22% — sustained multi-year profitability surge

507 employees as of March 31, 2024

Comparable Companies

CompanyTypeTickerMkt Cap

Gland Pharma LimitedListedGLAND~25,000 Cr

Ajanta Pharma LimitedListedAJANTPHARM~30,000 Cr

Indoco RemediesListedINDOCO~2,500 Cr

Gland Pharma LimitedListed

GLAND · ~25,000 Cr

Frequently Asked Questions

About Somerset Therapeutics

Somerset Therapeutics Private Limited is a Bengaluru-based pharmaceutical company incorporated on August 23, 1990, specializing in the development and manufacture of generic pharmaceutical formulations for regulated international export markets, primarily the United States. The company's CIN is U85110KA1990PTC011166, and its manufacturing facility is located in Boodihal Village, Nelamangala, Bangalore Rural. Somerset Therapeutics is the legal entity behind the Somerset Limited brand and is also associated with Wintac, an established Indian pharmaceutical company. The company focuses on injectables, ophthalmic (eye care) products, and capsules — dosage forms that require specialized manufacturing capabilities, cleanroom facilities, and stringent quality compliance for approval by the US FDA. The company reported exceptional revenue growth, reaching Rs 298 crore in FY2025 — a 35% growth rate with EBITDA CAGR of 154%, indicating rapid improvement in profitability alongside revenue expansion. As of March 2024, Somerset Therapeutics employed 507 people, reflecting a mid-sized pharmaceutical operation. The US generic pharmaceuticals market, which Somerset primarily targets, is the world's largest generics market, offering significant volume opportunities for Indian manufacturers who achieve US FDA plant approvals. Somerset's focus on injectable and ophthalmic dosage forms positions it in segments with higher entry barriers and better pricing than oral solid dosage (tablet) generics, potentially commanding better margins. With 35 years of pharmaceutical manufacturing experience since 1990 and accelerating revenue growth to Rs 298 Cr in FY2025, Somerset Therapeutics represents a significant player in India's specialty pharma export segment.

Key Milestones

1990 — Incorporated as Somerset Therapeutics Private Limited, ROC Bangalore, Karnataka

Common questions about unlisted shares

How do I buy Somerset Therapeutics unlisted shares here?
Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.
Who am I actually transacting with?
You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.
How do I pay, and is there a payment gateway?

Somerset Therapeutics Private Limited

How settlement works

Get price alerts for Somerset Therapeutics Private Limited

Discuss Somerset Therapeutics

Similar companies

Other ways to invest